Contact
Imprint & Disclaimer
Member login

Search ...

Username

Password

Remember Me

Forgot your username?
Forgot your password?

Home
About
CHI & AHH
Scientific Approach
For Patients & Relatives
LINKS

Hyperinsulinaemic hypoglycaemia caused by over functioning beta cells is a potentially lethal disease especially to infants. Our highly-innovative integrated therapy platform will allow diagnosis and guide therapeutic intervention.

Home >
Uncategorised

Print

BetaCure logo coloured
European emblem

BetaCure presentation layout

Page 47 of 56

Start
Prev
42
43
44
45
46
47
48
49
50
51
Next
End

Events 2018

31 May 2018	Final Summary Report ready for you to read!
31 March 2018	The BetaCure project has ended successfully

Important Links

Work Packages
Publications
Partner institutions

Top

Home

Project Summary
Facts & Figures
Coordinator and Project Office
Partners
Scientific and Ethical Advisory Board
News and Events

What is Congenital hyperinsulinism (CHI)?
Challenges in CHI therapy
What is Adult endogenous hyperinsulinaemic hypoglycemia (AHH)?
Challenges in AHH therapy
Current state-of-the-art of CHI and AHH therapy
Which innovative approaches can be used to overcome the current challenges of CHI and AHH therapy?

Background
Objectives
Strategy
Work packages
Publications

© 2020 BetaCure Legal Disclaimer

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602812. This website reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains.